Detalhe da pesquisa
1.
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial.
Antimicrob Agents Chemother
; 68(2): e0100423, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092664
2.
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
N Engl J Med
; 385(27): 2531-2543, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965338
3.
Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12â years and older: a PK substudy of the SMILE trial.
J Antimicrob Chemother
; 78(4): 1041-1049, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869720
4.
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
BMC Infect Dis
; 21(1): 5, 2021 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446115
5.
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
AIDS Behav
; 17(1): 193-202, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22584916
6.
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
EClinicalMedicine
; 60: 102025, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37304494
7.
Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
Antivir Ther
; 14(3): 423-32, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19474476
8.
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment.
J Antimicrob Chemother
; 63(6): 1223-32, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389715
9.
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.
HIV Med
; 10(10): 591-613, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19878352
10.
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.
Clin Infect Dis
; 46(10): 1601-8, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18419497
11.
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
PLoS One
; 13(4): e0196239, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684092
12.
Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.
J Pediatric Infect Dis Soc
; 6(3): e109-e115, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903520
13.
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
Antivir Ther
; 11(7): 857-67, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17302248
14.
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
AIDS
; 30(7): 1075-81, 2016 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26730569
15.
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
J Acquir Immune Defic Syndr
; 70(1): 42-53, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26322666
16.
Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission.
Lancet Infect Dis
; 15(9): 1108-1114, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26187030
17.
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Antivir Ther
; 7(4): 293-303, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12553485
18.
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
Antivir Ther
; 9(3): 415-21, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15259904
19.
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
Pediatr Infect Dis J
; 22(1): 48-55, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12544409
20.
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands.
Pediatr Infect Dis J
; 33(3): 301-5, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24356253